Skip to content
healthcare.dev
Get a free key

Imlygic

NDC 55513-079, talimogene laherparepvec, injection, suspension, from Amgen Inc.

Product NDC
55513-079
Status
Listed
Labeler
Amgen Inc
Dosage form
INJECTION, SUSPENSION
Route
INTRALESIONAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
BLA
Application
BLA125518
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/55513-079 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • TALIMOGENE LAHERPAREPVEC100000000 [PFU]/mL
Package NDCNDC-11Package
55513-079-01555130079011 VIAL in 1 CARTON (55513-079-01) / 1 mL in 1 VIAL

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/64ffb680-ea8c-42fc-9649-9e8c0eb77ddb

  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=55513-079

Use it

Look up 55513-079 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/55513-079 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 55513-079. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.